Detalhe da pesquisa
1.
Real-life experience with remdesivir for treatment of COVID-19 among older adults: a multicentre retrospective study.
J Antimicrob Chemother
; 78(6): 1505-1509, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086215
2.
Efficacy and tolerability of dolutegravir/lamivudine versus dolutegravir/rilpivirine in switching from a three-drug regimen based on nonnucleoside reverse transcriptase inhibitors: A retrospective cohort study.
J Med Virol
; 95(10): e29149, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37805832
3.
Non-B subtypes account for a large proportion of clustered primary HIV-1 infections in Italy.
Sex Transm Infect
; 99(1): 53-56, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35443987
4.
Genotypic HIV-1 tropism determination might help to identify people with exhausted treatment options and advanced disease.
J Antimicrob Chemother
; 76(12): 3272-3279, 2021 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34529797
5.
Virological response and resistance profile in highly treatment-experienced HIV-1-infected patients switching to dolutegravir plus boosted darunavir in clinical practice.
HIV Med
; 22(6): 519-525, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33480094
6.
Long-term maintenance of virologic suppression in native and migrant HIV-1 naïve patients: an Italian cohort study.
AIDS Care
; 33(9): 1159-1166, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33172289
7.
Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy.
Sex Transm Infect
; 95(8): 619-625, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31076456
8.
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program.
Clin Infect Dis
; 64(5): 680-683, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28011605
9.
Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains.
J Clin Microbiol
; 55(9): 2827-2837, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28701420
10.
Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study.
BMC Infect Dis
; 16(1): 401, 2016 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27515949
11.
Shall We Dance? Extending TANGO's Results to Clinical Practice.
Clin Infect Dis
; 71(7): e200-e201, 2020 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32198516
12.
Comparing the efficacy and safety of a first-line regimen with emtricitabine/tenofovir alafenamide fumarate plus either bictegravir or dolutegravir: Results from clinical practice.
Int J Antimicrob Agents
; 63(1): 107040, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37981074
13.
Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumonia.
Front Med (Lausanne)
; 11: 1293431, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38529120
14.
Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort.
J Antimicrob Chemother
; 68(1): 200-5, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22915463
15.
Real world efficacy of dolutegravir plus lamivudine in people living with HIV with undetectable viral load after previous failures.
J Glob Antimicrob Resist
; 32: 158-163, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36402369
16.
Efficacy of Dolutegravir versus Darunavir in Antiretroviral First-Line Regimens According to Resistance Mutations and Viral Subtype.
Viruses
; 15(3)2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36992471
17.
Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients.
Viruses
; 15(5)2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37243208
18.
Predictors of survival in elderly patients with coronavirus disease 2019 admitted to the hospital: derivation and validation of the FLAMINCOV score.
Clin Microbiol Infect
; 29(3): 379-385, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36191845
19.
Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC vs. B/F/TAF: the DEBATE trial.
Front Immunol
; 14: 1279390, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37908359
20.
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study.
Viruses
; 15(2)2023 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36851508